HomeCLDX • NASDAQ
Celldex Therapeutics Inc
Follow
$16.85
7.16%
Pre-market:(4.45%)-0.75
$16.10
Closed: Apr 2, 4:06:41 AM GMT-4 · USD · NASDAQ · Disclaimer
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 1.18M | -71.56% |
Operating expense | 10.26M | 16.20% |
Net income | -47.09M | -8.74% |
Net profit margin | -4.01K | -282.31% |
Earnings per share | -0.71 | -19.91% |
EBITDA | -55.21M | -60.64% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 725.28M | 71.22% |
Total assets | 792.34M | 70.17% |
Total liabilities | 45.34M | 24.36% |
Total equity | 747.01M | — |
Shares outstanding | 66.38M | — |
Price to book | 1.61 | — |
Return on assets | -17.34% | — |
Return on capital | -18.19% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -47.09M | -8.74% |
Cash from operations | -32.48M | 0.18% |
Cash from investing | 24.05M | 114.05% |
Cash from financing | 386.00K | -99.82% |
Net change in cash | -8.04M | -158.79% |
Free cash flow | -16.87M | -88.80% |
Previous close
$18.15
Day range
$16.75 - $18.03
Year range
$16.75 - $47.00
Market cap
1.12B USD
Avg Volume
745.82K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1983
Headquarters
Website
Employees
186
